• Research & Development

  Yutrepia enrolls its first participant and is eagerly awaiting FDA approval.

  Posted by jen-cueva on January 16, 2024 at 12:50 pm

  Exciting news! The first participant has been enrolled in the Yutrepia for PH-ILD program. We’re eagerly awaiting potential FDA approval, which is expected in February. If you haven’t already, check out the latest story from our PH News team by clicking the link below.
  

  “Open-label clinical trial of Yutrepia for PH-ILD enrolls 1st participant“
  
  As we move into 2024, there is hope as we explore new treatment possibilities for our PH community. Please share your takeaways with us.

  jen-cueva replied 3 months, 2 weeks ago 1 Member · 0 Replies

  • enrolls
  • FDA approval
  • PH-ILD
  • Yutrepia
• 0 Replies

Log In to Reply